On Rare Diseases Day 2019, the University of Oxford and Harrington Discovery Institute at University Hospitals have announced a new affiliation to advance therapies for rare diseases.
The Oxford-Harrington Rare Disease Centre will bring together the capabilities, resources and expertise of both institutions to deliver new treatments for rare diseases, for which therapeutic options are lacking.
More than 350 million people worldwide are living with a rare disease, and approximately 50 percent of those are children. Here, we speak to Professor Matthew Wood, a professor of Neuroscience in the Department of Paediatrics, about his work and the advances that a new Rare Diseases Centre could herald for the future of rare disease and genetics.
Read more (Medium website)
Oxford-Harrington Rare Disease Centre news story (University of Oxford website)